Please login to the form below
44
Revenue 2017Gardasil/ Gardasil 9
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Gardasil/ Gardasil 9 was produced by Merck & Co..
Merck & Co’s sales bounce back in ‘ongoing recovery from COVID-19’
Most notably, sales of the company’s human papillomavirus (HPV) vaccine Gardasil increased by 88% to $1.2bn, primarily due to recovery from the pandemic and strong demand in the US.
Keytruda growth helps Merck to offset COVID-19 impact in Q3
While sales of its papillomavirus vaccine Gardasil declined due to lower demand in the US and Hong Kong thanks to the COVID-19 pandemic, Merck reported higher sales of its pneumococcal
MSD hangs ‘for sale’ sign on French facility, shedding 207 staff
Its recent investments in manufacturing reflect that shift, and have been pitched at improving capacity for Keytruda and other growth products like human papillomavirus (HPV) vaccine Gardasil 9, which has been ... The company is planning a $1bn expansion
Merck CFO: we’re not only about Keytruda
vaccine Gardasil and HIV franchise – is evidence there is “a lot internally…to be excited about”. ... Turning to its other products, Gardasil grew 26% in the quarter to $1.3bn, while chickenpox vaccine Varivax rose 19% to $623m.
MSD taps Austria’s Themis to bolster vaccine pipeline
Vaccines remain a big part of its business however, growing 33% to $2 billion on the back of big gains for its Gardasil human papillomavirus (HPV) franchise in the send quarter
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
- Sanofi and Teva to collaborate on inflammatory bowel disease drug in deal worth $1.5bn
- Eli Lilly to acquire cancer specialist Point Biopharma in deal worth $1.4bn
- Regeneron and Intellia to develop additional gene editing therapies under expanded collaboration
- Novavax’s updated COVID-19 vaccine approved by FDA for emergency use
- Alzheimer’s Research UK awards Cardiff University researchers £387,000
- Actinic keratosis – a common skin condition that can lead to skin cancer
No results were found
PMHub
Havas Lynx Group
We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...
Latest intelligence
- Actinic keratosis – a common skin condition that can lead to skin cancer
- PMGroup talks to Volker Koscielny, Chief Medical Officer at Almirall, about the importance of remaining vigilant about skin checks, the prevalence of actinic keratosis in the UK and the steps...
- Man vs microbe: the fight against antimicrobial resistance
- How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics...
- Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital
- Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...
